Form 4: J.H. Whitney Equity Partners VII Sells $3.9 Million in Aveanna Healthcare Shares Under Pre-Arranged Plan

J.H. Whitney Equity Partners VII, a significant shareholder and director of Aveanna Healthcare Holdings, Inc., reported the sale of 750,000 shares of common stock for approximately $3.9 million under a Rule 10b5-1 trading plan.

Summary

• J.H. Whitney Equity Partners VII, LLC, identified as both a Director and a 10% Owner of Aveanna Healthcare Holdings, Inc. (AVAH), reported a transaction on June 10, 2025.
• The reporting person disposed of 750,000 shares of Aveanna Healthcare common stock at a price of $5.2 per share.
• This sale was conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating a pre-scheduled transaction.
• The total value of the shares sold amounts to $3,900,000.
• Following this transaction, J.H. Whitney Equity Partners VII, LLC, through its affiliated entities, beneficially owns a total of 45,922,481 shares of common stock.
• Specifically, 28,890,756 shares are held indirectly by J.H. Whitney VII, L.P., 15,588,582 shares by PSA Healthcare Investment Holding LLC, and 1,443,143 shares by PSA Iliad Holdings LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a large insider sale can be perceived negatively, the fact that it was executed under a pre-planned 10b5-1 program mitigates concerns that it's based on new, adverse information. The reporting person also retains a substantial stake.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, which suggests the sale was pre-scheduled and not based on new, undisclosed material information, potentially mitigating negative market perception.
• Despite the sale, J.H. Whitney Equity Partners VII and its affiliates retain a substantial beneficial ownership of 45,922,481 shares, indicating continued significant investment in Aveanna Healthcare.

Negatives

• A large insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the direct equity exposure of a significant owner and director.
• The sale of 750,000 shares represents a notable reduction in the direct holdings managed by the reporting person, potentially signaling a diversification strategy rather than a strong conviction in future stock appreciation.

Risks

• Market perception: Despite the 10b5-1 plan, a large insider sale could lead to short-term negative sentiment or increased selling pressure on Aveanna Healthcare's stock.
• Liquidity impact: The sale of a significant block of shares could temporarily impact the stock's liquidity or trading dynamics.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding Aveanna Healthcare Holdings, Inc.'s future performance or outlook.

Industry Context

This filing is a standard insider transaction report and does not provide specific insights into broader industry trends within the healthcare services sector. It reflects a change in ownership by a significant institutional investor and director.

Related Party Transactions

• The sale of 750,000 shares by J.H. Whitney Equity Partners VII, LLC, a 10% owner and director, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May react to the news of a significant insider sale, potentially leading to short-term stock price volatility, although the 10b5-1 plan may temper negative reactions.

Key Dates

Keywords

Aveanna Healthcare Holdings, AVAH, Form 4, Insider Sale, J.H. Whitney Equity Partners VII, Beneficial Ownership, Rule 10b5-1, Healthcare Services, Equity Transaction